Remove Article Remove Myocardial Infarction Remove Thrombosis
article thumbnail

TAVI Matches SAVR in Lower Risk Aortic Valve Patients: 10 year outcomes

Cardiology Update

Patients were evaluated based on a composite outcome of all-cause mortality, stroke, or myocardial infarction. Bioprosthetic valve dysfunction (BVD) was categorized into structural valve deterioration (SVD), non-structural valve dysfunction (NSVD), clinical valve thrombosis, or endocarditis. Original article: Thyregod HGH et al.

article thumbnail

Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). Methods We conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles.

article thumbnail

Immediate vs. multistage revascularization of non-infarct coronary artery(-ies) in patients with hemodynamically stable multivessel disease acute myocardial infarction: a systematic review and meta-analysis

Coronary Artery Disease Journal

Background Untreated multivessel disease (MVD) in acute myocardial infarction (AMI) has been linked to a higher risk of recurrent ischemia and death within one year. Databases were searched for relevant articles published before 10 November 2023.

article thumbnail

Role of Left Ventricular Ejection Fraction in Modern High-Risk PCI with pLVAD Support

Cardiology Update

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

article thumbnail

Why we need continuous 12-lead ST segment monitoring in Wellens' syndrome

Dr. Smith's ECG Blog

Here is the classic article on continuous 12-lead monitoring (in full text) showing that the ECG is a much more reliable indicator of re-occlusion than are symptoms. Here is another classic article. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. de Wood et al.

article thumbnail

Apixaban versus vitamin K antagonists in patients with antiphospholipid syndrome: a cohort study

Journal of Cardiovascular Pharmacology

Current guidelines recommend that direct anticoagulants should not be used in prevention of recurrent thrombosis in patients with antiphospholipid syndrome (APS). During a median follow-up of 53 months, we recorded venous thromboembolism (VTE), ischemic stroke or myocardial infarction, along with major bleeding.

article thumbnail

Upon arrival to the emergency department, a senior emergency physician looked at the ECG and said "Nothing too exciting."

Dr. Smith's ECG Blog

In a recent article (J Electrocardiol this year, see reference below), peak trop onin I levels in takotsubo presenting with ST Elevation were median 1.02 Note 2: This article fails to specify whether it was troponin I or T, but I contacted the institution and they used exclusively troponin I during that time period.

Plaque 52